Pharmafile Logo
Pharmafocus logo
Advanced Search

transparency

Showing 15 posts of 93 posts found.

Riwal image

Clinical trials transparency: the journey so far

May 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency

There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …

Feature
ema_building_face_web

EMA transparency agenda sees more delay

April 9, 2014
Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency

The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …

News
Glenis Willmott

EU votes for trial transparency

April 3, 2014
Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …

News
AstraZeneca image

AstraZeneca opens up research

March 28, 2014
Medical Communications, Sales and Marketing AstraZeneca, data, research, transparency, website

AstraZeneca has created a new means of sharing some of its data with scientists, such as its bank of live …

News
EU flag image

Data transparency debate: Europe decides its future

March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …

Feature
Novartis image

Novartis extends trial transparency

February 27, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Goldacre, Novartis, alltrials, transparency

Novartis has become the latest pharmaceutical company to allow greater scrutiny of its clinical trial data.

News
J&J image

J&J reveals more on transparency policy

February 3, 2014
Medical Communications, Research and Development, Sales and Marketing Goldacre, J&J, JJ, alltrials, johnson, transparency, yoda

Johnson & Johnson’s pharma subsidiary Janssen has given Pharmafile more details on its new transparency policy, which will see both …

News
Johnson and Johnson image

UPDATED: J&J in ‘game-changing’ data disclosure plan

January 30, 2014
Medical Communications, Research and Development, Sales and Marketing J&J, JJ, all trials, data, transparency, yoda

News

NHS patient data to be shared with researchers

January 6, 2014
Medical Communications, Research and Development, Sales and Marketing NHS, data, online, transparency

NHS England will begin to gather patient data from GPs for the first time this spring to ‘improve care and …

News
GSK image

GSK and Sanofi expand transparency

January 6, 2014
Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency

GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …

News
nhs_parliament_2_1

MPs ‘surprised and concerned’ over data transparency

January 3, 2014
Medical Communications, Sales and Marketing Cochrane, Godlee, Goldacre, Roche, Tamiflu, transparency

News

Europe to vote on greater trial transparency

December 17, 2013
Research and Development, Sales and Marketing EU, Europe, Goldacre, alltrials, transparency

Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …

News
GSK image

GSK changes sales tactics

December 17, 2013
Medical Communications, Sales and Marketing GSK, Witty, bribery, corruption, cuts, sales, transparency

GlaxoSmithKline is to remove individual staff sales targets and end doctor payments for activities that promote its products.  The UK …

News
EMA image

Court annuls EMA data decision

December 5, 2013
Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency

The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …

News

UPDATED: Pfizer first on trial transparency

December 5, 2013
Medical Communications, Sales and Marketing EMA, Goldacre, Pfizer, alltrials, transparency

News

Latest content

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment

November 27, 2023

Alladapt Immunotherapeutics gains FDA Fast Track Designation for ADP101 as food allergy treatment

November 24, 2023